Author/Creator: Skrabs, C. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Skrabs, C.

1. BTK inhibition is a potent approach to block IgE‐mediated histamine release in human basophils. Issue 11 (20th April 2017)

Authors:: Smiljkovic, D.; Blatt, K.; Stefanzl, G.; Dorofeeva, Y.; Skrabs, C.; Focke‐Tejkl, M.; Sperr, W. R.; Jaeger, U.; Valenta, R.; Valent, P.
Journal:: Allergy
Issue:: Volume 72:Issue 11(2017:Nov.)
Page Start:: 1666
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. BTK inhibition is a potent approach to block IgE‐mediated histamine release in human basophils. Issue 11 (20th April 2017)

Authors:: Smiljkovic, D.; Blatt, K.; Stefanzl, G.; Dorofeeva, Y.; Skrabs, C.; Focke‐Tejkl, M.; Sperr, W. R.; Jaeger, U.; Valenta, R.; Valent, P.
Journal:: Allergy
Issue:: Volume 72:Issue 11(2017:Nov.)
Page Start:: 1666
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Molecular classification of tumour cells in a patient with intravascular large B‐cell lymphoma. (1st January 2018)

Authors:: Bauer, W.M.; Aichelburg, M.C.; Griss, J.; Skrabs, C.; Simonitsch‐Klupp, I.; Schiefer, A.I.; Kittler, H.; Jäger, U.; Zeyda, M.; Knobler, R.; Stingl, G.
Journal:: British journal of dermatology
Issue:: Volume 178:Number 1(2018)
Page Start:: 215
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Molecular classification of tumour cells in a patient with intravascular large B‐cell lymphoma. (29th December 2017)

Authors:: Bauer, W.M.; Aichelburg, M.C.; Griss, J.; Skrabs, C.; Simonitsch‐Klupp, I.; Schiefer, A.I.; Kittler, H.; Jäger, U.; Zeyda, M.; Knobler, R.; Stingl, G.
Journal:: British journal of dermatology
Issue:: Volume 178:Number 1(2018)
Page Start:: 215
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Rapid decline in insulin antibodies and glutamic acid decarboxylase autoantibodies with ibrutinib therapy of chronic lymphocytic leukaemia. (28th July 2017)

Authors:: Skrabs, C.; Pickl, W. F.; Perkmann, T.; Jäger, U.; Gessl, A.
Journal:: Journal of clinical pharmacy and therapeutics
Issue:: Volume 43:Number 1(2018)
Page Start:: 145
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. UNMAINTAINED REMISSION AFTER DISCONTINUATION OF KINASE INHIBITOR TREATEMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA: AN OBSERVATIONAL COHORT. (12th June 2019)

Authors:: Egle, A.; Jäger, U.; Skrabs, C.; Dürig, J.; Nösslinger, T.; Wanner, D.; Steurer, M.; Ringshausen, I.; Melchardt, T.; Greil, R.; Ysebaert, L.
Journal:: Hematological oncology
Issue:: Volume 37(2019)Supplement 2
Page Start:: 218
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗